FIELD: medicine, cardiology.
SUBSTANCE: invention can be used to assess the risk of developing acute decompensation of heart failure in the long term in patients with heart failure after implantation of a cardioverter-defibrillator. The method is based on the assessment of 7 parameters: gender, left ventricular ejection fraction (LVEF), left atrium (LA) size in cm, functional class of heart failure according to NYHA, the presence of an angiotensin-converting enzyme inhibitor (ACEI), an angiotensin II receptor antagonist (ARA) in target doses, and amiodarone. The risk of developing acute decompensation of heart failure (P) is calculated using the original formula. If P is above 50%, a high probability of developing acute decompensation of heart failure in the long term is predicted.
EFFECT: method makes it possible to predict with high accuracy the risk of developing acute decompensation of heart failure and over a long period of observation (at least 4 years) in patients with low left ventricular ejection fraction and an implanted cardioverter-defibrillator, taking into account adherence to optimal drug therapy, can be used in stage of decision-making on implantation of a cardioverter-defibrillator, as well as when planning the intensity of subsequent outpatient observation.
1 cl, 1 dwg, 3 tbl, 2 ex
